Quarterly Revenues - OREXIGEN THERAPEUTICS INC (OREX)

OREX's price rose $0.01 to $7.28 two days after the 8/8/13 announcement.

Q2 2013

8 analyst estimates

$1.0M

High

$857K

Low

$909K

Consensus

Actual revenue of $857K, a negative surprise of -0.06%.

OREX's price fell $-0.04 to $5.51 two days after the 11/14/13 announcement.

Q3 2013

0 analyst estimates

--

High

--

Low

--

Consensus

Actual revenue of $857K.

OREX's price rose $0.58 to $7.55 two days after the 3/14/14 announcement.

Q4 2013

8 analyst estimates

$1.1M

High

$857K

Low

$939K

Consensus

Actual revenue of $857K, a negative surprise of -0.09%.

OREX's price rose $0.22 to $5.66 two days after the 5/10/14 announcement.

Q1 2014

5 analyst estimates

$1.1M

High

$857K

Low

$943K

Consensus

Actual revenue of $857K, a negative surprise of -0.09%.

OREX's price rose $0.23 to $5.63 two days after the 8/9/14 announcement.

Q2 2014

1 analyst estimates

$857K

High

$857K

Low

$857K

Consensus

Estimated revenue of $857K.

Q3 2014

1 analyst estimates

$3.6M

High

$3.6M

Low

$3.6M

Consensus

Estimated revenue of $3.6M.

Q4 2014

Orexigen Therapeutics, Inc.'s Quarterly Revenues

Orexigen Therapeutics, Inc. had 2nd quarter 2014 revenues of $857.0K USD. This missed the $942.8K USD consensus estimate of the 5 analysts following the company. This was the same as the prior year's 2nd quarter results.

Annual Revenues - OREXIGEN THERAPEUTICS INC (OREX)

8 analyst estimates

$3.4M

High

$3.0M

Low

$3.4M

Consensus

Actual revenue of $3.4M. This met the consensus of the 8 analysts.

OREX's price fell $-0.45 to $5.63 two days after the 3/15/13 announcement.

2012

7 analyst estimates

$3.4M

High

$3.0M

Low

$3.3M

Consensus

Actual revenue of $3.4M, a positive surprise of 1.04%.

OREX's price rose $0.58 to $7.55 two days after the 3/14/14 announcement.

2013

4 analyst estimates

$104M

High

$6.1M

Low

$79.6M

Consensus

Estimated revenue of $79.6M.

2014

8 analyst estimates

$64.9M

High

$16.0M

Low

$42.7M

Consensus

Estimated revenue of $42.7M.

2015

Orexigen Therapeutics, Inc.'s Annual Revenues

Orexigen Therapeutics, Inc. had revenues for the full year 2013 of $3.4M USD. This was the same as the prior year's results.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.